Screening For BCRL In Targeted Therapy For Breast Cancer

Inclusion Criteria:

Subjects who are receiving treatment in the MGH Breast Cancer Center who are enrolled in a DF/HCC-regulated targeted therapy trial for the treatment of early or metastatic breast cancer or patients being treated with a targeted therapy that may alter their risk of developing edema or BCRL will be eligible.
Subjects that will be eligible for the study include:
Females between 18 and 80 years of age
With a history of breast cancer
4 weeks or more post-surgery
With or without edema
Undergoing treatment with targeted therapy for early or metastatic disease.

Exclusion Criteria:

- Patients who cannot attain 90 degrees of shoulder abduction (position of measurement with Perometer).